Cargando…
Efficacy of flurbiprofen 8.75 mg delivered as a spray or lozenge in patients with sore throat due to upper respiratory tract infection: a randomized, non-inferiority trial in the Russian Federation
OBJECTIVE: To assess the efficacy of flurbiprofen 8.75 mg delivered as a spray or lozenge in patients with sore throat due to upper respiratory tract infection (URTI). MATERIALS AND METHODS: This multicenter, double-blind, double-dummy, non-inferiority study randomized 440 adults with recent-onset,...
Autores principales: | Radkova, Eugenia, Burova, Natalia, Bychkova, Valeria, DeVito, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505534/ https://www.ncbi.nlm.nih.gov/pubmed/28740426 http://dx.doi.org/10.2147/JPR.S135602 |
Ejemplares similares
-
Improvements in throat function and qualities of sore throat from locally applied flurbiprofen 8.75 mg in spray or lozenge format: findings from a randomized trial of patients with upper respiratory tract infection in the Russian Federation
por: Burova, Natalia, et al.
Publicado: (2018) -
Locally Delivered Flurbiprofen 8.75 mg for Treatment and Prevention of Sore Throat: A Narrative Review of Clinical Studies
por: de Looze, Ferdinandus, et al.
Publicado: (2019) -
Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method
por: Turner, Rob, et al.
Publicado: (2021) -
A Systematic Review of Flurbiprofen 8.75 mg Dose and Risk of Haemorrhagic Events
por: Dhanda, Sandeep, et al.
Publicado: (2021) -
Bactericidal activity of hexylresorcinol lozenges against oropharyngeal organisms associated with acute sore throat
por: Matthews, Derek, et al.
Publicado: (2020)